Cytomegalovirus reactivation risk after autologous hematopoietic stem cell transplantation: Results of a Tunisian study
CMV reactivation occurs in a noteworthy proportion of AHSCT recipients and may lead to severe outcomes. Routine VL monitoring in the early post-transplant period is crucial, and preemptive therapy should be initiated once clinically relevant VL thresholds are reached to prevent progression to CMV disease and associated mortality.
Authors
- Manel Hamdoun (ORCID: https://orcid.org/0000-0001-8175-1743)
- Olfa Bahri (ORCID: https://orcid.org/0000-0002-0610-2708)
- Medhat Moussa (ORCID: https://orcid.org/0000-0002-5394-043X)
- R. Kharrat
- Rabeb Berred
- Raihane Ben Lakhal
- Yasmine Chelbi
Institutions
- Tunis University (TN)
- Faculté de médecine de Tunis
- Tunis El Manar University (TN)
Publication Details
- Journal
- World Journal of Virology
- Published
- 2025-12-25
- DOI
- https://doi.org/10.5501/wjv.v14.i4.115626
- Citations
- 1
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 1.35